Avanos Medical, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Avanos Medical, Inc. reported a significantly reduced net loss in 2025, driven by strategic acquisitions and divestitures, despite ongoing restructuring costs and a goodwill impairment.
NYSE
10-K: Avanos Medical Reports Significant Goodwill and Intangible Asset Impairments in 2024 Annual Results
Avanos Medical's 2024 Form 10-K reveals substantial goodwill and intangible asset impairments, impacting operating results despite a slight increase in net sales.
NYSE
Avanos Medical Inc. has released its 2023 annual report, outlining financial results, strategic shifts, and ongoing restructuring efforts.